A 71-year-old woman, enrolled in the RAndomized study with the sirolimus (SRL)-eluting Bx VELocity balloonexpandable stent (RAVEL) Trial (December 5, 2000) , received a single SRL-eluting Bx Velocity stent (Cordis) to treat an 80% proximal left anterior descending (LAD) coronary artery stenosis ( Figure 1A) . Intravascular ultrasound and angiography at 6 months showed 0% stenosis with no in-stent neointimal proliferation ( Figure 1, B and D). The patient remained asymptomatic until presenting with unstable angina on May 3, 2002. Angiography demonstrated subtotal occlusion of the left obtuse marginal. The LAD SRL-eluting stent (deployed 16 months previously) showed 0% stenosis ( Figure  1C ). The left obtuse marginal lesion was successfully stented, but the patient suffered a fatal stroke 24 hours after coronary intervention.
At autopsy, the LAD SRL-eluting stent was widely patent, and there was a minute thrombus at the ostium of a small side branch (Figure 2A ). The stent surface was otherwise well healed. Light microscopy showed mild neointimal thickening (smooth muscle cells within a proteoglycan-rich matrix; Figure 2 , B through D). Fibrin was occasionally identified near stent struts, especially within the necrotic core, and was minimal within the neointima (Figure 2 , E and F). Inflammatory cells were rare. Scanning electron microscopy showed Ͼ80% endothelialization of the stent ( Figure 2G ). There were small foci of poorly formed endothelial cell junctions and rare platelet aggregates close to the side branch ostium associated with pavement-shaped endothelial cells (Figure 2, H and I) .
This SRL-eluting stent was widely patent at 16 months with Ͼ80% endothelial coverage. Neointimal healing was nearly complete, with only rare fibrin deposits. Figure 2 . The longitudinally cut Bx Velocity stent (A) has a translucent neointima and a small thrombus (arrow) at the distal end (at the ostium of a small side branch [white arrowhead]). A thin neointima (n) with rare giant cells (arrows) close to the strut (*) is shown in B. In C, 2 struts (*) are seen with one strut embedded in the necrotic core (**); note mild neointimal (n) formation. In D, a focal medial tear (arrow) with a strut (*) in contact with the external elastic lamina and adventitia is present. The overlying neointima (n) consists of a proteoglycan matrix containing numerous smooth muscle cells, which are shown in the boxed inset (␣-actin stain). Fibrin stains (E and F, corresponding to D and C, respectively) demonstrate minimal surface staining (E) and strong staining around the strut (F) within the necrotic core. Scanning electron microscopy of the stent (G) shows Ͼ80% surface coverage by endothelium with minimal focal nonendothelialization at the distal end (arrow). In H and I, endothelial cells are pavement shaped with poorly formed cell junctions and a small surface platelet aggregate (arrow in I). B through D: Movat pentachrome stain.
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